The number of physician assistants in the US grew by 28% from 2018 to 2022, and continued growth is predicted in coming years. The PA profession remains highly representative of women, with the gender distribution little changed in the past four years. Women account...
By Joe Gorelick, MSN, FNP-C This is very exciting information that may allow us to make early interventions that may modify to course of diseases. Analysis of tape strip samples from two-month babies predicted the likelihood of developing food allergies by age of two,...
By Joe Gorelick, MSN, FNP-C What’s new in the treatment of advanced melanoma? A second-generation melanoma vaccine appears to provide greater benefit than a first-generation vaccine, according to data from UVA Cancer Center, where the new vaccine was developed. The...
As many as seven in 10 people with eczema report that the disease has had a negative impact on their mental health in the past year. About two-thirds of adults with eczema had anxiety scores that were “borderline abnormal” or “abnormal,” and...
The FDA has accepted the New Drug Application (NDA) from Journey Medical Corp. for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40mg) for the treatment of inflammatory lesions and erythema of rosacea in adults. The FDA has set a Prescription Drug User...
By Joe Gorelick, MSN, FNP-C How many patients do you see with contact dermatitis? Negative patch testing results can be so frustrating and perhaps this year’s Allergen of the Year—sulfites–could be the culprit. Sulfites, commonly used preservatives in consumer...
